Literature DB >> 9338651

Superiority of hyperpolarizing to depolarizing cardioplegia in protection of coronary endothelial function.

G W He1, C Q Yang.   

Abstract

OBJECTIVE: Hyperpolarizing cardioplegia has recently been proposed for myocardial protection. To compare the protective effect of hyperpolarizing cardioplegia and depolarizing (hyperkalemic) cardioplegia on coronary endothelium, we studied porcine coronary arteries in the organ chamber.
METHODS: Relaxation mediated by the endothelium-derived hyperpolarizing factor (EDHF) was used as the index of endothelial function because (1) hyperkalemia without ischemia does not impair the nitric oxide-mediated function according to previous studies and (2) EDHF relaxes vessels by hyperpolarizing the membrane potential. Therefore depolarizing cardioplegia may inhibit this function, but hyperpolarizing cardioplegia may preserve it. EDHF-mediated relaxation was induced by bradykinin and the calcium ionophore A23187 with the presence of indomethacin (7 micromol/L; INN: indometacin), a cyclooxygenase inhibitor, and N(G)-nitro-L-arginine (300 micromol), a nitric oxide biosynthesis inhibitor in U46619 (30 nmol/L)-induced precontraction. The vessels were exposed to either hyperpolarizing cardioplegic solution (the potassium-channel opener aprikalim, 0.1 mmol/L) or depolarizing cardioplegic solution (high potassium concentration, 20 mmol/L for A23187 and 50 mmol/L for bradykinin experiments) for 1 hour with a constant supply of oxygen to exclude the effect of ischemia.
RESULTS: EDHF-mediated relaxation was significantly impaired in either A23187 or bradykinin studies (80.1% +/- 7.5% vs 24.9% +/- 14.2%, p = 0.004, n = 8 in each group for A23187, and 71.4% +/- 4.7%, n = 13, vs 40.5% +/- 12.9%, n = 7, p = 0.01, for bradykinin). The effective concentration causing 50% of maximal relaxation was significantly increased in the A23187 experiments with the treatment of hyperkalemia. In contrast, in aprikalim-treated arteries, the EDHF-mediated relaxation induced by either A23187 or bradykinin was unchanged.
CONCLUSIONS: We conclude that EDHF-mediated coronary endothelial function is maximally preserved by hyperpolarizing cardioplegia but impaired by depolarizing cardioplegia. These findings support the use of hyperpolarizing cardioplegia in cardiac operations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338651     DOI: 10.1016/S0022-5223(97)70055-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Effects of potassium channel opener KRN4884 on human conduit arteries used as coronary bypass grafts.

Authors:  Z Ren; S Floten; A Furnary; M Liu; H Gately; J Swanson; A Ahmad; A P Yim; G W He
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

2.  Del Nido Cardioplegia-Not Just Kids Stuff.

Authors:  Linda B Mongero
Journal:  J Extra Corpor Technol       Date:  2016-06

3.  New strategy of endothelial protection in cardiac surgery: use of enhancer of endothelial nitric oxide synthase.

Authors:  Hong-Mei Xue; Guo-Wei He; Jun-Hao Huang; Qin Yang
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

Review 4.  Theoretical and Practical Aspects in the Use of Bretschneider Cardioplegia.

Authors:  Claudiu Ghiragosian; Marius Harpa; Alexandra Stoica; Flămînd Oltean Sânziana; Radu Bălău; Hussam Al Hussein; Ghiragosian-Rusu Simina Elena; Radu Mircea Neagoe; Horațiu Suciu
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-02

Review 5.  Protection of coronary endothelial function during cardiac surgery: potential of targeting endothelial ion channels in cardioprotection.

Authors:  Qin Yang; Cheuk-Man Yu; Guo-Wei He; Malcolm John Underwood
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.